Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Jeremiah Boles"'
Autor:
Raj S. Kasthuri, Jeremiah Boles, Rachel M. Hollingsworth, Julie C. Williams, Jianguo Wang, A. Phillip Owens, Nigel Mackman, Nigel S. Key, David A. Barcel, Sam L. Glover
Publikováno v:
Thrombosis Research. 129:197-203
Introduction Cancer associated thrombosis is a well-recognized phenomenon that results in considerable patient morbidity and mortality. Malignancy conveys an increased risk for thrombosis and chemotherapy further elevates this risk. The pathophysiolo
Autor:
D.A. Barcel, Julie C. Williams, Jianguo Wang, Nigel S. Key, Rebecca D. Lee, David Manly, Nigel Mackman, Jeremiah Boles
Publikováno v:
Thrombosis Research. 129:80-85
Tissue factor (TF) is a transmembrane protein that is the primary initiator of the coagulation cascade. TF is constitutively expressed on perivascular cells and epithelial cells and activates the clotting cascade in the event of vascular injury [1–
Publikováno v:
Archives of Gynecology and Obstetrics. 284:303-306
Acute lymphocytic leukemia (ALL) is a rare occurrence in pregnancy and can be rapidly fatal if left untreated. The need for immediate treatment of ALL, coupled with the maternal-fetal risks from the chemotherapy regimen render a therapeutic dilemma i
Publikováno v:
Journal of Thrombosis and Haemostasis. 9:1429-1431
Autor:
Jeremiah Boles, William Culbreth
Publikováno v:
2013 Abstracts IEEE International Conference on Plasma Science (ICOPS).
Summary form only given. Pulsed gaseous fission reactors can be used to provide a transient source of neutrons for research or for power production. A mixture of gaseous, enriched UF6 and He may serve as the fuel and moderator for this design1. By us
Venous thromboembolism (VTE) is a leading cause of morbidity and mortality worldwide. However, the mechanisms by which clots are formed in the deep veins have not been determined. Tissue factor (TF) is the primary initiator of the coagulation cascade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dac4cc1acbdb71ada8e05da051052e83
https://europepmc.org/articles/PMC3076951/
https://europepmc.org/articles/PMC3076951/
Publikováno v:
Seminars in thrombosis and hemostasis. 36(7)
The tissue factor (TF)/factor (F)VIIa complex is the primary initiator of coagulation in vivo. Tissue factor pathway inhibitor (TFPI) is the physiological inhibitor of the TF/FVIIa complex. Deficiencies of either TF or TFPI have not been reported in
Autor:
Aaron James Scott, Bert H. O'Neil, Wen Wee Ma, Steven J. Cohen, Dara Aisner, Alex R. Menter, Mohamedtaki Abdulaziz Tejani, Jonathan K. Cho, Peter Rubin, Andrew L. Coveler, Olugbenga Olanrele Olowokure, Joaquina Celebre Baranda, Mike Cusnir, Philip Agop Philip, Jeremiah Boles, Robert T. Maguire, Francois Wilhelm, Manoj Maniar, Christina Gomes, Wells A. Messersmith
Publikováno v:
Journal of Clinical Oncology. 33:4117-4117
Autor:
Raj S. Kasthuri, A.P. Owens, Nigel Mackman, Jeremiah Boles, Nigel S. Key, D.A. Barcel, Sam L. Glover
Publikováno v:
Thrombosis Research. 125:S180-S181